CML Frontline Treatment Choice and Monitoring
By
Dana-Farber Cancer Institute
FEATURING
Daniel J. DeAngelo
By
Dana-Farber Cancer Institute
FEATURING
Daniel J. DeAngelo
Login to view comments.
Click here to Login